Shares of Meta Platforms ($FB.OQ) traded down over 20% after the social media giant reported worse-than-expected results for the December quarter and a disappointing outlook.

What did Meta's earnings report reveal?

Investors were given a reality check last night after the Street punished Meta Platforms in an unprecedented manner given the company's market valuation of nearly $900 billion. Roughly $200 billion was wiped off FB's market value in a matter of minutes after the company reported earnings per share (EPS) of $3.67, lower than the $3.84 Bloomberg consensus.

Meta Platforms also reported sales of $33.67 billion, slightly better than the $33.43 billion. However, the FB stock was hit heavily once investors started to digest below-the-surface numbers. Facebook daily and monthly active users came in at 1.93 billion and 2.91 billion, both missing the consensus of 1.95 billion and 2.95 billion, respectively. The operating margin also missed the benchmark number, coming in at 37% vs 38.7% estimate.

Facebook's owner is calling for revenue between $27 billion and $29 billion with the midpoint of the range coming in much lower than the $30.25 consensus. Expenses are seen at $92.5 billion at the midpoint of the full-year outlook, slightly higher than the $92.5 billion median analyst estimate.

Forward-looking commentary in the press release also didn't impress investors as Facebook said it expects "continued headwinds from both increased competition for people's time and a shift of engagement within our apps towards video surfaces like Reels, which monetize at lower rates than Feed and Stories."

As a result, Meta Platforms' stock price fell over 20% in after-hours Thursday trading. Several Wall Street analysts have already lowered ratings on the stock, as well as their price targets.

Any top-line miss or disappointing guidance is likely to result in another sharp selloff. Some analysts argue that following FB's miss, some earnings results have now become more important than the NFP print.

IMPORTANT NOTICE: Any news, opinions, research, analyses, prices or other information contained in this article are provided as general market commentary and do not constitute investment advice. The market commentary has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and therefore, it is not subject to any prohibition on dealing ahead of dissemination. Past performance is not an indication of possible future performance. Any action you take upon the information on this article is strictly at your own risk, and we will not be liable for any losses and damages in connection with the use of this article.

RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76.85% of retail client investors lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Related articles
A big upside in NFP fails to impress investors
Markets react to the 4 February NFP release
Key Commodity and Pharma market trends to watch in 2022
Share article

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

NAGA Group AG published this content on 04 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 February 2022 11:49:01 UTC.